Reset filter
Keywords
Atrial Fibrillation ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

313 Search results.

Relevance Rating New first Old first

Eligibility Syncope NCT01965899

- 9/28/21 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System; ODM derived from: https://clinicaltrials.gov/show/NCT01965899

CHA2DS2-VASc score

- 9/27/21 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: CHADS2
The CHA2DS2-VASc is a simple stroke risk stratification schema for patients with atrial fibrillation which is based on a risk factor approach and provides some improvement in predictive value for TE over the CHADS 2 schema. Reference: Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest Journal, 137(2), 263-272.

Eligibility Atrial Fibrillation NCT00580216

- 9/20/21 - 1 form, 1 itemgroup, 11 items, 1 language
Itemgroup: Inclusion Criteria
Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT00580216

Eligibility Atrial Fibrillation NCT00249795

- 9/20/21 - 1 form, 2 itemgroups, 20 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I); ODM derived from: https://clinicaltrials.gov/show/NCT00249795

Eligibility Atrial Fibrillation NCT02426944

- 9/20/21 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT02426944

Eligibility Atrial Fibrillation NCT02273700

- 9/20/21 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention; ODM derived from: https://clinicaltrials.gov/show/NCT02273700

Eligibility Atrial Fibrillation NCT02168829

- 9/20/21 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02168829

Eligibility Atrial Fibrillation NCT02071680

- 9/20/21 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Autonomic Innervation and MIBG Imaging; ODM derived from: https://clinicaltrials.gov/show/NCT02071680

Eligibility Atrial Fibrillation NCT00126022

- 9/20/21 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00126022

Eligibility Atrial Fibrillation NCT00126074

- 9/20/21 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00126074

Eligibility Atrial Fibrillation NCT00829478

- 9/20/21 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making; ODM derived from: https://clinicaltrials.gov/show/NCT00829478

Eligibility NCT00293943 Atrial Fibrillation - Eligibility

- 9/17/21 - 1 form, 3 itemgroups, 56 items, 2 languages
Itemgroups: Inclusion Criteria,Exclusion Criteria,Medical Concepts
ODM derived from http://clinicaltrials.gov/show/NCT00293943

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial